Lipikar - Triple Repair Lipid-Replenishing Balm 72h

LIPIKAR BAUME AP+MAX is enriched with a new technology, Neurobioma technology. It helps reduce sensations of itching. The technology helps to limit the proliferation of Staphylococcus aureus, a bacterium involved in atopic dermatitis, and to inhibit itch mediators, molecules responsible for the sensation of scratching. 24h anti-itch efficacy. Rebalances the skin microbiome and helps space out bouts of severe dryness. Triple repair, 72h relief for dry skin, soothes immediately.

How to apply the Lipikar AP+MAX balm by La Roche Posay? Apply it to areas where the skin is dry and prone to atopic eczema. It absorbs quickly to make daily application easier and faster. For best results, apply it to clean skin after using the Syndet Ap+ Lipikar shower cream or huile lavante AP+ Lipikar.

Where should you apply the Lipikar AP+MAX balm for dry skin prone to atopic eczema by La Roche Posay? This dry-skin cream can be applied to the body and face.

When should you apply the Lipikar AP+MAX balm for dry skin prone to atopic eczema by La Roche Posay? Apply this dry-skin cream once a day to your face and body.

Warning: product ingredient lists are regularly updated. Before using any product, please read the list of ingredients on the packaging to ensure that it is suitable for your personal use.

2039118 41 - INGREDIENTS:  AQUA / WATER / EAU • BUTYROSPERMUM PARKII BUTTER / SHEA BUTTER • GLYCERIN • DIMETHICONE • NIACINAMIDE • CETEARYL ALCOHOL • BRASSICA CAMPESTRIS SEED OIL / RAPESEED SEED OIL • GLYCERYL STEARATE • AMMONIUM POLYACRYLOYLDIMETHYL TAURATE • PEG-100 STEARATE • PROPANEDIOL • OPHIOPOGON JAPONICUS ROOT EXTRACT • PISUM SATIVUM EXTRACT / PEA EXTRACT • SORBITAN TRISTEARATE • DIMETHICONOL • PEG-20 METHYL GLUCOSE SESQUISTEARATE • SODIUM CHLORIDE • CYCLODEXTRIN • MANNOSE • COCO-BETAINE • DISODIUM EDTA • CAPRYLOYL GLYCINE • CAPRYLYL GLYCOL • VITREOSCILLA FERMENT • MALTODEXTRIN • XANTHAN GUM • TOCOPHEROL • PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE (F.I.L. N70067503/1).
Disclaimer